Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT02116972

Public ClinicalTrials.gov record NCT02116972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 9:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to assess the magnitude and duration of pain relief of a single IA injection of 2 doses (16 and 32 mg) of FX006, an extended-release formulation of TCA, relative to normal saline (placebo control).

Study identification

NCT ID
NCT02116972
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pacira Pharmaceuticals, Inc
Industry
Enrollment
310 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2014
Primary completion
Oct 31, 2015
Completion
Oct 31, 2015
Last update posted
Jan 23, 2024

2014 – 2015

United States locations

U.S. sites
39
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
Not listed Anniston Alabama 36207
Not listed Birmingham Alabama 35216
Not listed Mobile Alabama 36608
Not listed Phoenix Arizona 85023
Not listed Tucson Arizona 85704
Not listed Hot Springs Arkansas 71913
Not listed Anaheim California 92801
Not listed Canoga Park California 91303
Not listed El Cajon California 92020
Not listed Los Angeles California 90036
Not listed North Hollywood California 91606
Not listed San Diego California 92103
Not listed Stamford Connecticut 06905
Not listed DeLand Florida 32720
Not listed Fort Lauderdale Florida 33316
Not listed Orlando Florida 32825
Not listed Pinellas Park Florida 33781
Not listed Tampa Florida 33613
Not listed Marietta Georgia 30060
Not listed Evansville Indiana 47713
Not listed Paducah Kentucky 42003
Not listed Wheaton Maryland 20902
Not listed New Bedford Massachusetts 02740
Not listed Troy Michigan 48085
Not listed Kansas City Missouri 64114
Not listed Las Vegas Nevada 89106
Not listed Albuquerque New Mexico 87102
Not listed New York New York 10018
Not listed Rochester New York 14609
Not listed Raleigh North Carolina 27612
Not listed Oklahoma City Oklahoma 73112
Not listed Altoona Pennsylvania 16602
Not listed Duncansville Pennsylvania 16635
Not listed Mt. Pleasant South Carolina 29464
Not listed Dallas Texas 75231
Not listed Houston Texas 77055
Not listed San Antonio Texas 78258
Not listed Victoria Texas 77901
Not listed Danville Virginia 24541

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02116972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 23, 2024 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02116972 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →